Literature DB >> 26093846

Morphological study of upper airways and long-term follow-up of obstructive sleep apnea syndrome in acromegalic patients.

Cinzia Castellani1, Giuseppe Francia1, Luca Dalle Carbonare1, Marcello Ferrari1, Elena Viva2, Roberto Cerini3, Alessandro Zaccarella3, Lorenzo Trevisiol4, Maria Vittoria Davi'5.   

Abstract

Pathogenesis and long-term outcome of obstructive sleep apnea syndrome (OSAS) in acromegalic patients are still under debate. The aim of the study was to assess the prevalence and long-term follow-up of a series of acromegalic patients with OSAS and to investigate site, degree, and possible causes of upper airway obstruction by morphological study. Cross-sectional and longitudinal study was conducted in 58 acromegalic patients (33 active, 25 controlled) with polysomnography in all subjects, repeated in 25 patients with OSAS, and echocardiography. Morphological study including fiberoptic nasopharyngoscopy with the Müller maneuver (FNMM), magnetic resonance imaging (MRI), with 3-dimensional (3D) elaboration was also performed. The prevalence of OSAS was 58.6 % in the whole series: 63.6 % in the active group and 52 % in the controlled one. Left ventricular hypertrophy was more prevalent in patients with OSAS. OSAS improved in 62.5 % of active patients after achieving hormonal control, whereas it persisted or got worse in 66.6 % of the controlled ones. The uvula and tongue base were the main site of obstruction assessed by FNMM. Uvula diameters obtained by MRI study correlated with the severity of upper airway collapse assessed by FNMM and tongue measure with apnea-hypopnea index (p = 0.044). A greater narrowing and a smaller total volume of upper airways were confirmed by 3D-MRI in patients with more severe OSAS. Uvula and tongue hypertrophy plays a relevant role in the pathogenesis and severity of OSAS. Intensive treatment of acromegaly needs to be promptly adopted in order to reverse it.

Entities:  

Keywords:  Acromegaly; IGF-1; Pathogenesis; Sleep apnea syndrome

Mesh:

Year:  2015        PMID: 26093846     DOI: 10.1007/s12020-015-0659-x

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  30 in total

Review 1.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.

Authors: 
Journal:  Sleep       Date:  1999-08-01       Impact factor: 5.849

2.  Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging.

Authors:  Flávia R B van Haute; Giselle F Taboada; Lívia L Corrêa; Giovanna A B Lima; Rosita Fontes; Anna Patricia Riello; Michele Dominici; Mônica R Gadelha
Journal:  Eur J Endocrinol       Date:  2008-04       Impact factor: 6.664

3.  Effect of transsphenoidal surgery on sleep apnoea in acromegaly.

Authors:  Lisa Sze; Christoph Schmid; Konrad E Bloch; René Bernays; Michael Brändle
Journal:  Eur J Endocrinol       Date:  2007-03       Impact factor: 6.664

4.  Sleep apnoea in treated acromegaly: relative frequency and predisposing factors.

Authors:  F Rosenow; S Reuter; U Deuss; B Szelies; R D Hilgers; W Winkelmann; W D Heiss
Journal:  Clin Endocrinol (Oxf)       Date:  1996-11       Impact factor: 3.478

5.  Craniofacial abnormalities and their relevance for sleep apnoea syndrome aetiopathogenesis in acromegaly.

Authors:  S Dostalova; K Sonka; Z Smahel; V Weiss; J Marek; D Horinek
Journal:  Eur J Endocrinol       Date:  2001-05       Impact factor: 6.664

Review 6.  Disorders of glucose metabolism in sleep apnea.

Authors:  Naresh M Punjabi; Vsevolod Y Polotsky
Journal:  J Appl Physiol (1985)       Date:  2005-11

7.  Sleep apnea in acromegaly.

Authors:  R R Grunstein; K Y Ho; C E Sullivan
Journal:  Ann Intern Med       Date:  1991-10-01       Impact factor: 25.391

8.  Determinants of clinical outcome and survival in acromegaly.

Authors:  C Rajasoorya; I M Holdaway; P Wrightson; D J Scott; H K Ibbertson
Journal:  Clin Endocrinol (Oxf)       Date:  1994-07       Impact factor: 3.478

9.  Sleep apnoea and daytime sleepiness in acromegaly: relationship to endocrinological factors.

Authors:  T Pekkarinen; M Partinen; R Pelkonen; M Iivanainen
Journal:  Clin Endocrinol (Oxf)       Date:  1987-12       Impact factor: 3.478

Review 10.  Obstructive sleep apnea: implications for cardiac and vascular disease.

Authors:  Abu S M Shamsuzzaman; Bernard J Gersh; Virend K Somers
Journal:  JAMA       Date:  2003-10-08       Impact factor: 56.272

View more
  10 in total

1.  Sleep apnea syndrome in acromegalic patients: Can morphological evaluation guide us to optimize treatment?

Authors:  Ana M Ramos-Levi; Mónica Marazuela
Journal:  Endocrine       Date:  2015-10-30       Impact factor: 3.633

2.  Densely granulated adenoma pattern is associated with an increased risk of obstructive sleep apnea in patients with acromegaly.

Authors:  Xianchao Zhao; Lijun Heng; Yan Qu; Dong Jia; Jiafeng Ren; Shuyu Sun; Jian Qiu; Jinxiang Cheng; Ting Yang; Junying Zhou; Changjun Su
Journal:  Sleep Breath       Date:  2021-08-12       Impact factor: 2.655

3.  High levels of IGF-1 predict difficult intubation of patients with acromegaly.

Authors:  Yu Zhang; Xiaopeng Guo; Lijian Pei; Zhuhua Zhang; Gang Tan; Bing Xing
Journal:  Endocrine       Date:  2017-06-15       Impact factor: 3.633

4.  Temporal relationship of sleep apnea and acromegaly: a nationwide study.

Authors:  Konstantina Vouzouneraki; Karl A Franklin; Maria Forsgren; Maria Wärn; Jenny Tiberg Persson; Helena Wik; Christina Dahlgren; Ann-Sofie Nilsson; Caroline Alkebro; Pia Burman; Eva-Marie Erfurth; Jeanette Wahlberg; Anna-Karin Åkerman; Charlotte Høybye; Oskar Ragnarsson; Britt Edén Engström; Per Dahlqvist
Journal:  Endocrine       Date:  2018-07-31       Impact factor: 3.633

Review 5.  Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 1: Diagnostic and Clinical Issues.

Authors:  Renato Cozzi; Maria R Ambrosio; Roberto Attanasio; Alessandro Bozzao; Laura De Marinis; Ernesto De Menis; Edoardo Guastamacchia; Andrea Lania; Giovanni Lasio; Francesco Logoluso; Pietro Maffei; Maurizio Poggi; Vincenzo Toscano; Michele Zini; Philippe Chanson; Laurence Katznelson
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2020       Impact factor: 2.895

Review 6.  Acromegaly, inflammation and cardiovascular disease: a review.

Authors:  Thalijn L C Wolters; Mihai G Netea; Niels P Riksen; Adrianus R M M Hermus; Romana T Netea-Maier
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

7.  Evaluation of Acromegaly patients with sleep disturbance related symptoms.

Authors:  Deniz Celik; Sezgi Sahin Duyar; Funda Aksu; Selma Firat; Bulent Ciftci
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 2.340

8.  Prevalence of acromegaly in patients with symptoms of sleep apnea.

Authors:  Gemma Sesmilo; Eugenia Resmini; Marcel Sambo; Concepción Blanco; Fernando Calvo; Fernando Pazos; Pablo Fernández-Catalina; Purificación Martínez de Icaya; Concepción Páramo; Carmen Fajardo; Mónica Marazuela; Cristina Álvarez-Escolá; Juan Jose Díez; Verónica Perea
Journal:  PLoS One       Date:  2017-09-12       Impact factor: 3.240

9.  Evaluation of the pharyngeal airway using computational fluid dynamics in patients with acromegaly.

Authors:  Keika Mukaihara; Maiko Hasegawa-Moriyama; Tomonori Iwasaki; Youichi Yamasaki; Yuichi Kanmura
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-03-25

10.  The Course of Obstructive Sleep Apnea Syndrome in Patients With Acromegaly During Treatment.

Authors:  Thalijn L C Wolters; Sean H P P Roerink; Linda C A Drenthen; Jolanda H G M van Haren-Willems; Margaretha A E M Wagenmakers; Johannes W A Smit; Adrianus R M M Hermus; Romana T Netea-Maier
Journal:  J Clin Endocrinol Metab       Date:  2020-01-01       Impact factor: 5.958

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.